Perigon Wealth Management LLC Has $9.60 Million Holdings in Procter & Gamble Company (The) $PG

Perigon Wealth Management LLC lessened its holdings in Procter & Gamble Company (The) (NYSE:PG) by 10.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 66,983 shares of the company’s stock after selling 7,417 shares during the period. Perigon Wealth Management LLC’s holdings in Procter & Gamble were worth $9,599,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Emprise Bank grew its holdings in shares of Procter & Gamble by 2.5% during the 3rd quarter. Emprise Bank now owns 2,766 shares of the company’s stock valued at $425,000 after purchasing an additional 68 shares during the last quarter. Affiance Financial LLC lifted its stake in Procter & Gamble by 2.5% in the 3rd quarter. Affiance Financial LLC now owns 2,803 shares of the company’s stock valued at $431,000 after purchasing an additional 69 shares during the last quarter. Beech Hill Advisors Inc. boosted its position in Procter & Gamble by 0.5% in the fourth quarter. Beech Hill Advisors Inc. now owns 14,238 shares of the company’s stock valued at $2,040,000 after buying an additional 70 shares in the last quarter. Dominguez Wealth Management Solutions Inc. boosted its position in Procter & Gamble by 0.3% in the third quarter. Dominguez Wealth Management Solutions Inc. now owns 20,464 shares of the company’s stock valued at $3,144,000 after buying an additional 71 shares in the last quarter. Finally, Aull & Monroe Investment Management Corp grew its stake in shares of Procter & Gamble by 0.3% during the fourth quarter. Aull & Monroe Investment Management Corp now owns 28,113 shares of the company’s stock worth $4,029,000 after buying an additional 71 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE PG opened at $143.06 on Friday. The company has a market capitalization of $332.46 billion, a price-to-earnings ratio of 21.19, a PEG ratio of 5.07 and a beta of 0.41. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $174.80. The stock has a fifty day simple moving average of $153.71 and a 200 day simple moving average of $149.79.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, January 23rd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The firm had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. During the same period in the previous year, the business earned $1.88 EPS. The business’s quarterly revenue was up 1.5% compared to the same quarter last year. Sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s payout ratio is currently 62.67%.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Supply Chain 3.0 — P&G is rolling out a “Supply Chain 3.0” program to link real‑time demand to production, aiming to cut waste, raise efficiency and improve long‑term margins and cash flow; this is a structural margin catalyst if execution scales. Is Procter & Gamble’s Supply Chain 3.0 a Catalyst for Margin Growth? Zacks: Supply Chain 3.0
• Positive Sentiment: OLAY peptide research — New clinical-backed peptide science from OLAY could accelerate product upgrades and premiumization in skincare, supporting revenue mix and brand momentum. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
• Positive Sentiment: Defensive / dividend appeal — As recession fears persist, PG’s low‑beta, dividend‑rich profile keeps it attractive to income and defensive buyers. As Recession Odds Climb, Defensive Sectors Continue to Outperform (PG) The 5 Safest Dividend Aristocrats
• Neutral Sentiment: Quarterly outlook — Analysts expect low single‑digit earnings growth for the coming quarter; execution vs. those modest expectations will drive near‑term reaction. What to Expect From Procter & Gamble’s Next Quarterly Earnings Report
• Neutral Sentiment: General analyst commentary — Various analyst notes and media pieces summarize P&G’s defensive positioning and competitive dynamics; useful context but mixed for immediate price action. Analysts Offer Insights on Consumer Goods Companies
• Negative Sentiment: TD Cowen trims target and estimates — TD Cowen cut its price target to $142 (maintained Hold) and lowered segment estimates, citing weaker pricing power; that reduction is pressuring sentiment. TD Cowen Flags Weaker Pricing Power, Trims P&G Target MarketScreener: TD Cowen Adjusts Price Target
• Negative Sentiment: Deutsche Bank cut target — Deutsche Bank lowered its target to $162 from $171 and highlighted inflation and currency headwinds as near‑term risks to margins. Deutsche Bank Highlights Inflation and Currency Headwinds for P&G

Insiders Place Their Bets

In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of the company’s stock in a transaction on Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the sale, the insider directly owned 44,735 shares of the company’s stock, valued at approximately $7,259,595.80. This represents a 25.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Gary A. Coombe sold 36,093 shares of the stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the sale, the chief executive officer owned 34,994 shares of the company’s stock, valued at approximately $5,680,576.02. This trade represents a 50.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 348,618 shares of company stock valued at $55,462,643 over the last three months. Insiders own 0.20% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on PG shares. Wells Fargo & Company reiterated an “overweight” rating and issued a $177.00 price target on shares of Procter & Gamble in a research note on Tuesday, February 17th. Jefferies Financial Group upgraded Procter & Gamble from a “hold” rating to a “buy” rating and increased their target price for the company from $156.00 to $179.00 in a research report on Tuesday, December 16th. Rothschild & Co Redburn lifted their price target on Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a research note on Friday, January 23rd. Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Finally, UBS Group raised their price objective on shares of Procter & Gamble from $161.00 to $170.00 and gave the company a “buy” rating in a report on Friday, January 23rd. Twelve analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $167.06.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.